Skip to main content
. 2021 Feb 15;220:153380. doi: 10.1016/j.prp.2021.153380

Fig. 3.

Fig. 3

No residual SARS-COV-2 is detected in post-COVID-19 lung sy from the patient. a, d. Lung tissue (Hematoxylin-Eosin). b, e. Immunohistochemistry of lung tissue is negative for SARS-CoV-2 nucleocapsid protein. c, f. Positive immunohistochemistry control for SARS-CoV-2 nucleocapsid protein.